Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Flexion Therapeutics (FLXN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 542,912
  • Shares Outstanding, K 37,860
  • Annual Sales, $ 360 K
  • Annual Income, $ -137,480 K
  • 36-Month Beta 1.17
  • Price/Sales 1,595.33
  • Price/Cash Flow N/A
  • Price/Book 4.07

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -1.21
  • Number of Estimates 3
  • High Estimate -1.11
  • Low Estimate -1.30
  • Prior Year -1.38
  • Growth Rate Est. (year over year) +12.32%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.11 +3.05%
on 12/10/18
17.73 -17.99%
on 11/15/18
-2.42 (-14.27%)
since 11/09/18
3-Month
13.36 +8.83%
on 11/01/18
22.12 -34.27%
on 09/12/18
-7.55 (-34.18%)
since 09/11/18
52-Week
13.36 +8.83%
on 11/01/18
29.10 -50.03%
on 06/20/18
-10.37 (-41.63%)
since 12/11/17

Most Recent Stories

More News
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced a grant of inducement stock options to five new employees for an aggregate of 24,150 shares of common stock. The Compensation Committee of the Board...

FLXN : 14.58 (+1.67%)
Flexion Therapeu Has Returned 31.4% Since SmarTrend Recommendation (FLXN)

SmarTrend identified a Downtrend for Flexion Therapeu (NASDAQ:FLXN) on July 27th, 2018 at $24.22. In approximately 4 months, Flexion Therapeu has returned 31.38% as of today's recent price of $16.62.

FLXN : 14.58 (+1.67%)
New Research Coverage Highlights Phibro Animal Health, RadNet, Amphastar Pharmaceuticals, FibroGen, Sientra, and Flexion Therapeutics -- Consolidated Revenues, Company Growth, and Expectations for 2018

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Phibro Animal Health Corporation...

PAHC : 33.15 (+0.27%)
SIEN : 16.99 (+1.86%)
AMPH : 22.12 (+0.55%)
FGEN : 40.46 (+3.64%)
FLXN : 14.58 (+1.67%)
RDNT : 12.73 (+1.52%)
Flexion Therapeu Shares Down 33.9% Since SmarTrend's Sell Call (FLXN)

SmarTrend identified a Downtrend for Flexion Therapeu (NASDAQ:FLXN) on July 27th, 2018 at $24.22. In approximately 4 months, Flexion Therapeu has returned 33.90% as of today's recent price of $16.01.

FLXN : 14.58 (+1.67%)
Flexion Therapeu Shares Down 33.7% Since SmarTrend's Sell Call (FLXN)

SmarTrend identified a Downtrend for Flexion Therapeu (NASDAQ:FLXN) on July 27th, 2018 at $24.22. In approximately 4 months, Flexion Therapeu has returned 33.73% as of today's recent price of $16.05.

FLXN : 14.58 (+1.67%)
Flexion Therapeutics Named Top Place to Work for Second Consecutive Year by The Boston Globe

Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it has been named one of the Top Places to Work in Massachusetts for the second consecutive year. The rankings are based on the results from...

FLXN : 14.58 (+1.67%)
Flexion Therapeu Down 30.0% Since SmarTrend Downtrend Call (FLXN)

SmarTrend identified a Downtrend for Flexion Therapeu (NASDAQ:FLXN) on July 27th, 2018 at $24.22. In approximately 4 months, Flexion Therapeu has returned 29.98% as of today's recent price of $16.96.

FLXN : 14.58 (+1.67%)
Flexion Therapeutics (FLXN) Reports Q3 Loss, Tops Revenue Estimates

Flexion Therapeutics (FLXN) delivered earnings and revenue surprises of 7.26% and 17.84%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?...

FLXN : 14.58 (+1.67%)
Flexion Therapeutics: 3Q Earnings Snapshot

BURLINGTON, Mass. (AP) _ Flexion Therapeutics Inc. (FLXN) on Wednesday reported a loss of $43.6 million in its third quarter.

FLXN : 14.58 (+1.67%)
Flexion Therapeutics Reports Third-Quarter 2018 Financial Results and Recent Business Highlights

Flexion Therapeutics, Inc. (Nasdaq:FLXN) today reported financial results and recent business highlights for the quarter ended September 30, 2018.

FLXN : 14.58 (+1.67%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade FLXN with:

Business Summary

Flexion Therapeutics, Inc. is a specialty pharmaceutical company. It is focused on the development and commercialization of injectable pain therapies. The Company is targeting anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. It operates in the United...

See More

Key Turning Points

2nd Resistance Point 15.36
1st Resistance Point 14.85
Last Price 14.50
1st Support Level 13.97
2nd Support Level 13.60

See More

52-Week High 29.10
Fibonacci 61.8% 23.09
Fibonacci 50% 21.23
Fibonacci 38.2% 19.37
Last Price 14.50
52-Week Low 13.36

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar